1[1]Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs[J]. Drug Saf,1996,15(1):53-56.
2[2]Tamai H, Sudo T, Kimura A,et al. Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease[J]. Ann intern Med,1996,124(5):490-494.
4[4]Chien MN, Wan CH, Tsan KW. Methimazole-induced agranulocytosis treated with recombinant human granulocyte[J]. Chung Hua I Hsueh Tsa Chin Taipei,1995,56(5):351-355.
5[5]Andres E, Maloisel F, Kurtz JE,et al. Do hematopoietic growth factors have a role in the treatment of drug-induced agranulocytosis?[J]. Rev Med Interne,2000,21(7):580-585.
7[7]Hara H, Ban Y, Sato R,et al. Change in serum G-CSF levels in patients with Graves disease by treatment with methimazole[J]. Nippon Naibunpi Gakkai Zasshi,1992,68(10):1121-1129.
8Balkin MS. Buch holtz M,Ortiz J. G,et al.Propylthiouracil-induced agranualocytosis treated with recombinant human granulocyte colony- stimulating factor(G-CSF)[].Thyroid.1993
9Tajiri J,Noguchi,S.Granulocyte colony stimulutiry factor treaor treatment of antithyroid drug-induced granulocytopenia[].Archives of Internal Medicine.1993
